Looking to publish in Journal of Autoimmunity? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowThe Journal of Autoimmunity publishes papers related to diverse aspects of autoimmunity, including the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases, with special attention to genetic, molecular biology, and cellular aspects of the discipline.
Looking to publish in Journal of Autoimmunity? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Journal of Autoimmunity accepts the following article types. Click on an article type to view submission instructions.
Full-Length Articles
Reviews
Short Communications
Recent Publications
Efficacy, safety, and tolerability of treatments for interstitial lung disease associated with rtoid arthritis: A systematic review and network meta-analysis
Yuwei Hu, Yujie Gan, Min Tang, Xiufang Xie, Xiaoli Zheng, Xiongyan Luo, Anji Xiong
Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition
Antonio Tonutti, Vlad Voiculescu, Francesca Trunfio, Kerem Abacar, Ala Altaie, Tom Macleod, Claire Vandevelde, Katya Meridor, Kave Shams, Alen Zabotti, Luca Quartuccio, Carlo Selmi, Helena Marzo-Ortega, Dennis McGonagle
Celiac disease plasma cells recognize the active form of transglutaminase 2 with and without bound substrate
Anna Vik Rødseth, Knut E.A. Lundin, Ludvig M. Sollid, Rasmus Iversen
A gradient of immune complexes induces directional migration and a lupus-associated transcriptional program in Slan+ non-classical monocytes
Michael Hertwig, Stephanie Oehrl, Thomas Döbel, Hao Zhang, Stefan Meisel, Amelie List, Knut Schäkel
Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillance
Shigeaki Suzuki, Minami Iida, Takuya Wakahara, Yuki Shiko, Hiroyuki Murai
Frequently asked questions
How long does it take to publish?
6 days submission to first decision; 31 days submission to decision after review; 103 days submission to acceptance; 8 days from acceptance to first online publication.
Reformat to Journal of Autoimmunity using Livewrite PremiumWhat are the publication costs?
Open Access APC: USD 5,150 (excluding taxes); subscription: no publication fee charged to authors.
Reformat to Journal of Autoimmunity using Livewrite Premium